Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$1.35 – $1.64
76% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.43B | $6.07B | $6.95B | $8.34B | $9.15B | $8.01B | $7.47B | $8.00B |
| Cost of revenue | $1.52B | $1.53B | $1.81B | $2.09B | $2.11B | $1.94B | $2.05B | $2.28B |
| Gross profit | $3.92B | $4.55B | $5.13B | $6.25B | $7.04B | $6.08B | $5.42B | $5.72B |
| Gross margin | 72.1% | 74.9% | 73.9% | 74.9% | 76.9% | 75.8% | 72.6% | 71.5% |
| R&D | $0 | $50.4M | $66.5M | $114.8M | $125.4M | $195.1M | $330.0M | $569.9M |
| Operating income | $2.28B | $2.64B | $2.76B | $3.15B | $3.55B | $2.71B | $1.73B | $1.54B |
| EBITDA | $2.20B | $2.75B | $3.05B | $3.70B | $3.76B | $2.92B | $2.31B | $1.80B |
| Net income | $1.85B | $1.96B | $2.53B | $3.02B | $3.26B | $2.40B | $1.62B | $1.45B |
| Net margin | 34.0% | 32.3% | 36.4% | 36.2% | 35.6% | 30.0% | 21.7% | 18.1% |
| EPS (diluted) | 0.74 | 0.79 | 1.02 | 1.22 | 1.33 | 0.98 | 0.67 | 0.60 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $10.1B | $0.82 | $0.73–$0.85 | 1 |
| 2027 | $12.3B | $0.98 | $0.87–$1.03 | 1 |
| 2028 | $15.0B | $1.19 | $1.06–$1.25 | 1 |
Forward consensus · source: Financial Modeling Prep
CHINA MEDICAL SYS HLDGS
No one on the platform currently holds CHSYF.
No tracked institution reports a position in CHSYF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-04-29 | $0.1550 | 2026-05-07 |
| 2025-09-02 | $0.1710 | 2025-09-09 |
| 2025-04-30 | $0.1270 | 2025-05-09 |
| 2024-08-30 | $0.1640 | 2024-09-09 |
| 2024-05-15 | $0.0860 | 2024-05-23 |
| 2023-09-12 | $0.3420 | 2023-09-20 |
No one on the platform has traded CHSYF yet.
| +0.00% |
| $2.6B |
| — |
| HAWPFHaw Par Corporation Limited | $12.00 | +0.00% | $2.7B | — |
| HMDCFHUTCHMED (China) Limited | $2.16 | +0.00% | $1.9B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.